AGC and RoosterBio partner for cell and exosome therapy manufacturing
Pharmaceutical Technology
AUGUST 17, 2022
Biopharmaceutical contract development and manufacturing organisation (CDMO) AGC Biologics has entered a strategic collaboration with RoosterBio to expedite the manufacturing of cell and exosome therapies. These capabilities comprise cell and exosome genetic engineering for expressing therapeutic targets.
Let's personalize your content